90359-73-2

Upstream product

• 7465-86-3 4-methoxy-N,N-diethylbenzamide 
• 74-88-4 methyl iodide 
• 31310-08-4 2-methyl-4-methoxybenzoyl chloride 
• 109-89-7 diethylamine 
• 6245-57-4 4-methoxy-2-methylbenzoic acid 

Downstream Products

• 90359-74-3 N,N-diethyl-2--4-methoxybenzamide 
• 122357-64-6 N,N-diethyl-2--4-methoxy-6-(trimethylsilyl)benzamide 
• 1078-19-9 6-methoxy-3,4-dihydro-1(2H)-naphthalenone 
• 1769-84-2 6-methoxy-2-phenyl-1-tetralone 
• 208345-52-2 N,N-Diethyl-4-methoxy-2-[(S)-2-phenyl-2-((S)-toluene-4-sulfinylamino)-ethyl]-benzamide 
• 630422-13-8 6-methoxy-3-phenylisoquinolin-1(2H)-one 
• 630423-67-5 N,N-diethyl-4-methoxy-2-(2-oxo-2-pyridin-3-yl-ethyl)-benzamide 
• 630422-15-0 N,N-diethyl-4-methoxy-2-(2-oxo-2-thiazol-2-yl-ethyl)-benzamide 
• 1240426-31-6 C₂₄H₃₆N₂O₅ 
• 1409950-18-0 3-(4-isopropoxyphenyl)-6-methoxyisoquinolin-1(2H)-one 
• 1409965-01-0 3-(4-(tert-butyl)-phenyl)-6-methoxyisoquinolin-1(2H)-one 
• 1409964-99-3 3-(4-(tert-butyl)-phenyl)-1-chloro-6-methoxyisoquinoline 
• 1409965-02-1 1-chloro-3-(4-isopropoxyphenyl)-6-methoxyisoquinoline 
• 1409950-48-6 1-chloro-3-(3-chloro-4-methoxyphenyl)-6-methoxyisoquinoline 

Relevant academic research and scientific papers

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Synthesis of 7-(4-piperidyl)- [1,6]naphthyridin-5-one and 3-(4-piperidyl)isoqunolin-1-one

7-(4-Piperidyl)[1,6]napththiridin-5-one was synthesized on the basis of 2-methylnicotinic acid. 3-(4-Piperidyl)isoquinolin-1-one was synthesized from the diethylamide of o-toluic acid and Weinreb′s amide of N-Boc-isonipecotic acid.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

HEPATITIS C VIRUS INHIBITORS

Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.

Directed Metalation of N,N-Diethylbenzamides. Silylated Benzamides for the Synthesis of Naturally Occurring pero-Methylanthraquinones and peri-Methyl Polycyclic Aromatic Hydrocarbons

Efficient methodologies based on directed ortho metalation, fluoride-induced carbodesilylation, and metal-halogen exchange processes (Scheme I) are reported for the synthesis of peri-methyl-substituted anthraquinone natural products 5 and polycyclic aroma

SILICON IN BENZAMIDE DIRECTED ORTHO METALATION REACTIONS SYNTHESIS OF PERI-METHYL SUBSTITUTED PAHs AND NATURAL ANTHRAQUINONES

The α,α-bis(trimethylsilyl)-o-toluamides 4 and 9, systems protected from benzylic deprotonation, are available starting materials for the short syntheses of peri-methyl substituted benz(a)anthraquinones 6a and 6b and desoxyerythrolaccin trimethyl ether 12 respectively.